ASCO News: Bristol and Pfizer report positive results

Chicago attracts thousands of people from the cancer world each year.Adam Feuerstein/STAT

Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall Street, and biotechnology. He is co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. Signal’s Adam can be reached at stataf.54.

Matthew Harper discusses medical innovation, both its promise and its perils.

Angus reports on basic research, clinical science and drug development that have the potential to change survival and quality of life for patients, as well as developments that impact the cancer community. You can access Angus.08 on Signal.

You are reading the web version of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology Annual Meeting. Sign up for the email version here.

We are ASCOmaxxing.

Rest assured, Adam Feuerstein, Matthew Harper, and Angus Chen don’t need to work on their jawlines. But they scour the ASCO Annual Meeting to bring you the cancer news, analysis, and event coverage you crave.

STAT+ exclusive story

This article is exclusive to STAT+ subscribers

Unlock this article and get in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plan Group plan See all plans

To read the rest of this story, subscribe to STAT+.

Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall Street, and biotechnology. He is co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. Signal’s Adam can be reached at stataf.54.
Senior Writer, Medicine, Event Editorial Director
Matthew Harper discusses medical innovation, both its promise and its perils.
Angus reports on basic research, clinical science and drug development that have the potential to change survival and quality of life for patients, as well as developments that impact the cancer community. You can access Angus.08 on Signal.